<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>58</patient-age><report-id>JP-CELGENEUS-087-21880-12123349</report-id><gender>male</gender><reactions><reaction>SUSPICION OF PULMONARY INFARCTION</reaction><reaction>DEEP VEIN THROMBOSIS</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>REVLIMID</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LENADEX</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>DECADRON</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>OXYCONTIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>AMLODIPINE BESILATE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>DAIPHEN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ACICLOVIR</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TAKEPRON</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>BORTEZOMIB</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>WARFARIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>VICCLOX</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>10051381</indication><indication>10057097</indication><indication>10020772</indication><indication>10049924</indication><indication>10017822</indication><indication>10028228</indication><indication>10043634</indication><indication>10019944</indication></indications><outcomes><outcome>Death</outcome></outcomes><country>Japan</country><geo/></meta><original><ichicsr lang="en" xmlns="">
  <ichicsrmessageheader lang="en">
    <messagetype>ichicsr</messagetype>
    <messageformatversion>2.1</messageformatversion>
    <messageformatrelease>2.0</messageformatrelease>
    <messagenumb>CEL000000000001289211</messagenumb>
    <messagesenderidentifier>CELGENE</messagesenderidentifier>
    <messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
    <messagedateformat>204</messagedateformat>
    <messagedate>20130125101300</messagedate>
  </ichicsrmessageheader>
  <safetyreport lang="en">
    <safetyreportversion lang="en">2</safetyreportversion>
    <safetyreportid lang="en">JP-CELGENEUS-087-21880-12123349</safetyreportid>
    <primarysourcecountry>JP</primarysourcecountry>
    <occurcountry>JP</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>2013-01-25</transmissiondate>
    <reporttype>1</reporttype>
    <serious code="1">Yes</serious>
    <seriousnessdeath>1</seriousnessdeath>
    <seriousnessother>1</seriousnessother>
    <receivedateformat>102</receivedateformat>
    <receivedate>2012-12-29</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>2013-01-18</receiptdate>
    <additionaldocument>2</additionaldocument>
    <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
    <companynumb lang="en">JP-CELGENEUS-087-21880-12123349</companynumb>
    <medicallyconfirm>1</medicallyconfirm>
    <primarysource>
      <reportergivename>Kubota</reportergivename>
      <reporterfamilyname>Hagiwara</reporterfamilyname>
      <reportercountry>JP</reportercountry>
      <qualification code="1">Physician</qualification>
    </primarysource>
    <sender>
      <sendertype>1</sendertype>
      <senderorganization>CELGENEUS</senderorganization>
      <senderdepartment>Global Drug Safety</senderdepartment>
      <sendertitle>Manager</sendertitle>
      <sendergivename>Vivian</sendergivename>
      <senderfamilyname>Fonseca</senderfamilyname>
      <senderstreetaddress>300 Connell Drive, Suite 6000</senderstreetaddress>
      <sendercity>Berkeley Heights</sendercity>
      <senderstate>NJ</senderstate>
      <senderpostcode>07922</senderpostcode>
      <sendercountrycode>US</sendercountrycode>
      <sendertel>9082190331</sendertel>
      <senderfax>9086739115</senderfax>
      <senderemailaddress>vfonseca@celgene.com</senderemailaddress>
    </sender>
    <receiver>
      <receivertype>2</receivertype>
      <receiverorganization>FDAPM</receiverorganization>
      <receivergivename>Roger</receivergivename>
      <receivermiddlename>A</receivermiddlename>
      <receiverfamilyname>Goetsch</receiverfamilyname>
      <receivercountrycode>US</receivercountrycode>
    </receiver>
    <patient lang="en">
      <patientinitial>Y-U</patientinitial>
      <patientbirthdateformat>102</patientbirthdateformat>
      <patientbirthdate>19540912</patientbirthdate>
      <patientsex code="1">Male</patientsex>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10011474</patientepisodename>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10047001</patientepisodename>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10061105</patientepisodename>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10001041</patientepisodename>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10050452</patientepisodename>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10000803</patientepisodename>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10037410</patientepisodename>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10061758</patientepisodename>
        <patientmedicalstartdateformat>610</patientmedicalstartdateformat>
        <patientmedicalstartdate>201101</patientmedicalstartdate>
      </medicalhistoryepisode>
      <patientdeath>
        <patientdeathdateformat>102</patientdeathdateformat>
        <patientdeathdate>20121216</patientdeathdate>
        <patientdeathcause>
          <patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
          <patientdeathreport>10037410</patientdeathreport>
        </patientdeathcause>
      </patientdeath>
      <reaction>
        <primarysourcereaction lang="en">SUSPICION OF PULMONARY INFARCTION</primarysourcereaction>
        <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
        <reactionmeddrallt>10037410</reactionmeddrallt>
        <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
        <reactionmeddrapt>10037410</reactionmeddrapt>
        <termhighlighted>3</termhighlighted>
        <reactionstartdateformat>102</reactionstartdateformat>
        <reactionstartdate>20121215</reactionstartdate>
        <reactionduration>1</reactionduration>
        <reactiondurationunit>804</reactiondurationunit>
        <reactionfirsttime>397</reactionfirsttime>
        <reactionfirsttimeunit>804</reactionfirsttimeunit>
        <reactionoutcome code="5">fatal</reactionoutcome>
      </reaction>
      <reaction>
        <primarysourcereaction lang="en">DEEP VEIN THROMBOSIS</primarysourcereaction>
        <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
        <reactionmeddrallt>10051055</reactionmeddrallt>
        <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
        <reactionmeddrapt>10051055</reactionmeddrapt>
        <termhighlighted>3</termhighlighted>
        <reactionstartdateformat>102</reactionstartdateformat>
        <reactionstartdate>20121215</reactionstartdate>
        <reactionfirsttime>397</reactionfirsttime>
        <reactionfirsttimeunit>804</reactionfirsttimeunit>
        <reactionoutcome code="6">unknown</reactionoutcome>
      </reaction>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20111031</testdate>
        <testname lang="en">INR</testname>
        <testresult>0.99</testresult>
        <lowtestrange>0.90</lowtestrange>
        <hightestrange>1.10</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20111031</testdate>
        <testname lang="en">HEMOGLOBIN</testname>
        <testresult>8.5</testresult>
        <testunit>g/dL</testunit>
        <lowtestrange>13.5</lowtestrange>
        <hightestrange>17.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20111031</testdate>
        <testname lang="en">PROTHROMBIN TIME</testname>
        <testresult>11.8</testresult>
        <testunit>secs</testunit>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20111031</testdate>
        <testname lang="en">PLATELET COUNT</testname>
        <testresult>132</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>150</lowtestrange>
        <hightestrange>350</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20111031</testdate>
        <testname lang="en">APTT</testname>
        <testresult>30</testresult>
        <testunit>secs</testunit>
        <lowtestrange>22.0</lowtestrange>
        <hightestrange>37.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20111031</testdate>
        <testname lang="en">PT</testname>
        <testresult>11.8</testresult>
        <testunit>secs</testunit>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20111031</testdate>
        <testname lang="en">RED BLOOD CELL COUNT</testname>
        <testresult>2410</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>4300</lowtestrange>
        <hightestrange>5700</hightestrange>
      </test>
      <test>
        <testdateformat>610</testdateformat>
        <testdate>201209</testdate>
        <testname lang="en">PTT</testname>
        <testresult>26.7</testresult>
        <testunit>secs</testunit>
        <lowtestrange>22.0</lowtestrange>
        <hightestrange>37.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20120903</testdate>
        <testname lang="en">Red blood cell count</testname>
        <testresult>2970</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>4300</lowtestrange>
        <hightestrange>5700</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20120903</testdate>
        <testname lang="en">INR</testname>
        <testresult>1.09</testresult>
        <lowtestrange>.90</lowtestrange>
        <hightestrange>1.10</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20120903</testdate>
        <testname lang="en">Hemoglobin</testname>
        <testresult>10.5</testresult>
        <testunit>g/dL</testunit>
        <lowtestrange>13.5</lowtestrange>
        <hightestrange>17.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20120903</testdate>
        <testname lang="en">APTT</testname>
        <testresult>26.7</testresult>
        <testunit>secs</testunit>
        <lowtestrange>22.0</lowtestrange>
        <hightestrange>37.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20120903</testdate>
        <testname lang="en">Platelet count</testname>
        <testresult>185</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>150</lowtestrange>
        <hightestrange>350</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20120903</testdate>
        <testname lang="en">PT</testname>
        <testresult>12.6</testresult>
        <testunit>secs</testunit>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121001</testdate>
        <testname lang="en">PT</testname>
        <testresult>12.8</testresult>
        <testunit>secs</testunit>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121001</testdate>
        <testname lang="en">Red blood cell count</testname>
        <testresult>2690</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>4300</lowtestrange>
        <hightestrange>5700</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121001</testdate>
        <testname lang="en">APTT</testname>
        <testresult>28.7</testresult>
        <testunit>secs</testunit>
        <lowtestrange>22.0</lowtestrange>
        <hightestrange>37.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121001</testdate>
        <testname lang="en">Platelet count</testname>
        <testresult>129</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>150</lowtestrange>
        <hightestrange>350</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121001</testdate>
        <testname lang="en">INR</testname>
        <testresult>1.11</testresult>
        <lowtestrange>0.90</lowtestrange>
        <hightestrange>1.10</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121001</testdate>
        <testname lang="en">Hemoglobin</testname>
        <testresult>9.7</testresult>
        <testunit>g/dL</testunit>
        <lowtestrange>13.5</lowtestrange>
        <hightestrange>17.0</hightestrange>
      </test>
      <test>
        <testdateformat>610</testdateformat>
        <testdate>201211</testdate>
        <testname lang="en">PROTHROMBIN TIME</testname>
        <testresult>12.2</testresult>
        <testunit>secs</testunit>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121126</testdate>
        <testname lang="en">HEMOGLOBIN</testname>
        <testresult>10.8</testresult>
        <testunit>g/dL</testunit>
        <lowtestrange>13.5</lowtestrange>
        <hightestrange>17.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121126</testdate>
        <testname lang="en">PLATELET COUNT</testname>
        <testresult>142</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>150</lowtestrange>
        <hightestrange>350</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121126</testdate>
        <testname lang="en">APTT</testname>
        <testresult>28.4</testresult>
        <testunit>secs</testunit>
        <lowtestrange>22.0</lowtestrange>
        <hightestrange>37.0</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121126</testdate>
        <testname lang="en">PT</testname>
        <testresult>12.2</testresult>
        <testunit>secs</testunit>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121126</testdate>
        <testname lang="en">INR</testname>
        <testresult>1.07</testresult>
        <lowtestrange>0.90</lowtestrange>
        <hightestrange>1.10</hightestrange>
      </test>
      <test>
        <testdateformat>102</testdateformat>
        <testdate>20121126</testdate>
        <testname lang="en">RED BLOOD CELL COUNT</testname>
        <testresult>3020</testresult>
        <testunit>thousand per micro liter</testunit>
        <lowtestrange>4300</lowtestrange>
        <hightestrange>5700</hightestrange>
      </test>
      <test>
        <testdateformat>610</testdateformat>
        <testdate>201212</testdate>
        <testname lang="en">OXYGEN SATURATION</testname>
        <testresult>55</testresult>
        <testunit>%</testunit>
      </test>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>REVLIMID</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugauthorizationnumb>21-880</drugauthorizationnumb>
        <drugauthorizationcountry>US</drugauthorizationcountry>
        <drugauthorizationholder>Celgene Corporation</drugauthorizationholder>
        <drugstructuredosagenumb>5</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>2</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">5 Milligram</drugdosagetext>
        <drugdosageform normalized="capsule">Capsules</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10051381</drugindication>
        <drugstartdateformat>102</drugstartdateformat>
        <drugstartdate>2011-11-14</drugstartdate>
        <drugstartperiod>397</drugstartperiod>
        <drugstartperiodunit>804</drugstartperiodunit>
        <actiondrug code="6">Not Applicable</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>LENALIDOMIDE</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10037410</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Probable</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10051055</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Probable</drugresult>
        </drugreactionrelatedness>
      </drug>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>LENADEX</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>20</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="803">Week</drugintervaldosagedefinition>
        <drugdosagetext lang="en">2.8571 Milligram</drugdosagetext>
        <drugdosageform normalized="tablet">Tablets</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10051381</drugindication>
        <drugstartdateformat>102</drugstartdateformat>
        <drugstartdate>2010-12-08</drugstartdate>
        <drugstartperiod>738</drugstartperiod>
        <drugstartperiodunit>804</drugstartperiodunit>
        <actiondrug code="6">Not Applicable</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>2454002</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10037410</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Probable</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10051055</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Probable</drugresult>
        </drugreactionrelatedness>
      </drug>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>DECADRON</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>3</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">3 Milligram</drugdosagetext>
        <drugdosageform normalized="tablet">Tablets</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10051381</drugindication>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>DEXAMETHASONE</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10051055</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Not Provided</drugresult>
        </drugreactionrelatedness>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>OXYCONTIN</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>10</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">10 Milligram</drugdosagetext>
        <drugdosageform normalized="unknown">Unknown</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10057097</drugindication>
        <activesubstance>
          <activesubstancename>OXYCODONE HYDROCHLORIDE</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>AMLODIPINE BESILATE</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>10</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">10 Milligram</drugdosagetext>
        <drugdosageform normalized="tablet">Tablets</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10020772</drugindication>
        <activesubstance>
          <activesubstancename>AMLODIPINE BESILATE</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>DAIPHEN</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugseparatedosagenumb>2</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="803">Week</drugintervaldosagedefinition>
        <drugdosagetext lang="en">1.1429 Tablet</drugdosagetext>
        <drugdosageform normalized="tablet">Tablets</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10049924</drugindication>
        <activesubstance>
          <activesubstancename>SULFAMETHOXAZOLE</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>ACICLOVIR</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>400</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">400 Milligram</drugdosagetext>
        <drugdosageform normalized="unknown">Unknown</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10057097</drugindication>
        <activesubstance>
          <activesubstancename>ACICLOVIR</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>TAKEPRON</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>15</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">15 Milligram</drugdosagetext>
        <drugdosageform normalized="tablet">Tablets</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10017822</drugindication>
        <activesubstance>
          <activesubstancename>LANSOPRAZOLE</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>BORTEZOMIB</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugdosageform normalized="unknown">Unknown</drugdosageform>
        <drugadministrationroute code="065">Unknown</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10028228</drugindication>
        <activesubstance>
          <activesubstancename>Bortezomib</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>WARFARIN</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>1</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">1 Milligram</drugdosagetext>
        <drugdosageform normalized="tablet">Tablets</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10043634</drugindication>
        <drugstartdateformat>102</drugstartdateformat>
        <drugstartdate>2011-02-28</drugstartdate>
        <drugenddateformat>102</drugenddateformat>
        <drugenddate>2012-12-15</drugenddate>
        <drugtreatmentduration>656</drugtreatmentduration>
        <drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
        <activesubstance>
          <activesubstancename>WARFARIN</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>VICCLOX</medicinalproduct>
        <obtaindrugcountry>JP</obtaindrugcountry>
        <drugstructuredosagenumb>400</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">400 Milligram</drugdosagetext>
        <drugdosageform normalized="tablet">Tablets</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10019944</drugindication>
        <activesubstance>
          <activesubstancename>ACICLOVIR</activesubstancename>
        </activesubstance>
      </drug>
      <summary lang="en">
        <narrativeincludeclinical><Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">DEEP VEIN THROMBOSIS</Semaphore>(JAPAN) <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">Initial </Semaphore>information was received on 29Dec2012 from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>regarding a <Semaphore x="1387834" class="Patient Age" value="58" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="58" score="1.00" ID="">58 </Semaphore>year old </Semaphore>male who received <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid </Semaphore><Semaphore x="1868834" class="Disease or Finding" value="Duration of Rupture of Membrane" score="1.00" ID="C113389">dose, duration </Semaphore>unspecified from Jan2011 to unknown date and 5mg every other day for 21 day cycle from 14/Nov/2011 for indication of <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple myeloma</Semaphore>. <Semaphore x="2352775" class="Procedure" value="Other Therapy" score="1.00" ID="C15645">Other suspect therapy </Semaphore>included Lenadex 20mg/week and <Semaphore x="434155" class="Medicine" value="Decadron" score="0.87" ID="249384">Decadron </Semaphore><Semaphore x="1864556972343297" class="Medicine - Decadron - Dose" value="3mg" score="0.49" ID="">3mg </Semaphore><Semaphore x="1864617101885441" class="Medicine - Decadron - Frequency" value="daily" score="0.49" ID="">daily </Semaphore>(both from unspecified date) for indication of <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple myeloma</Semaphore>. Medical history included in 2006 the patient developed <Semaphore x="2439896" class="Disease or Finding" value="Purpura" score="1.00" ID="C78787">purpura </Semaphore>of <Semaphore x="2104605" class="AnatomicStructure" value="Leg" score="1.00" ID="C32974">lower <Semaphore x="2112119" class="AnatomicStructure" value="Limb" score="1.00" ID="C12429">extremity </Semaphore></Semaphore>for which <Semaphore x="2886478" class="MedDRA LLT" value="Cryoglobulinaemia" score="1.00" ID="10011474">Cryoglobulinaemia </Semaphore>was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed</Semaphore>. In Dec2008: as generalized <Semaphore x="2439896" class="Disease or Finding" value="Purpura" score="1.00" ID="C78787">purpura </Semaphore>emerged and caused <Semaphore x="2459546" class="Disease or Finding" value="Renal Failure" score="1.00" ID="C4376"><Semaphore x="1426763" class="Disease or Finding" value="Acute Renal Failure" score="1.00" ID="C26808">acute <Semaphore x="2459546" class="Disease or Finding" value="Renal Failure" score="1.00" ID="C4376">renal failure</Semaphore></Semaphore>
      <Semaphore x="2906208" class="MedDRA LLT" value="Dialysis" score="1.00" ID="10061105">
       <Semaphore x="2014361" class="Procedure" value="Hemodialysis" score="1.00" ID="C15248">
        <Semaphore x="2014329" class="Disease or Finding" value="Hemodialysis Catheter-Associated Bacteremia" score="1.00" ID="C114728">
         <Semaphore x="2014311" class="Disease or Finding" value="Hemodialysis Catheter Infection" score="1.00" ID="C114724">
          </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
    <Semaphore x="2459546" class="Disease or Finding" value="Renal Failure" score="1.00" ID="C4376">
     <Semaphore x="2906208" class="MedDRA LLT" value="Dialysis" score="1.00" ID="10061105">
      <Semaphore x="2014361" class="Procedure" value="Hemodialysis" score="1.00" ID="C15248">
       <Semaphore x="2014329" class="Disease or Finding" value="Hemodialysis Catheter-Associated Bacteremia" score="1.00" ID="C114728">
        <Semaphore x="2014311" class="Disease or Finding" value="Hemodialysis Catheter Infection" score="1.00" ID="C114724">, </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
    <Semaphore x="2906208" class="MedDRA LLT" value="Dialysis" score="1.00" ID="10061105">
     <Semaphore x="2014361" class="Procedure" value="Hemodialysis" score="1.00" ID="C15248">
      <Semaphore x="2014329" class="Disease or Finding" value="Hemodialysis Catheter-Associated Bacteremia" score="1.00" ID="C114728">
       <Semaphore x="2014311" class="Disease or Finding" value="Hemodialysis Catheter Infection" score="1.00" ID="C114724">dialysis </Semaphore></Semaphore></Semaphore></Semaphore>was performed. In 2009, <Semaphore x="2237768" class="Procedure" value="Monoclonal Protein Measurement" score="1.00" ID="C92291">Monoclonal <Semaphore x="3208968" class="MedDRA LLT" value="Protein total" score="1.00" ID="10050537">protein </Semaphore></Semaphore>(<Semaphore x="2809177" class="MedDRA LLT" value="Blood immunoglobulin G" score="1.00" ID="10005593">IgG</Semaphore>) was <Semaphore x="1844858" class="Procedure" value="Detection" score="1.00" ID="C16210">detected </Semaphore>and autologous <Semaphore x="2392008" class="Procedure" value="Peripheral Stem Cell Transplant" score="1.00" ID="C29353"><Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">peripheral <Semaphore x="2390905" class="Disease or Finding" value="Peripheral Blood Eosinophilia" score="1.00" ID="C36234">blood </Semaphore></Semaphore>
     <Semaphore x="3261704" class="MedDRA LLT" value="Stem cell transplant" score="1.00" ID="10063581">
      <Semaphore x="2390927" class="Disease or Finding" value="Peripheral Blood Involvement" score="1.00" ID="C39593">
       <Semaphore x="2390905" class="Disease or Finding" value="Peripheral Blood Eosinophilia" score="1.00" ID="C36234">stem cell </Semaphore></Semaphore>transplant </Semaphore></Semaphore>was performed for <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosis </Semaphore>of Cryoblobulinaemia due to MGUS/SMM. On unknown date Botezomib <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>was initiated because as patient met criteria for <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple myeloma</Semaphore>. It was noted that in Jan2011 <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid </Semaphore>was started due to worsening of <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple myeloma </Semaphore>and that after start of <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid </Semaphore>the <Semaphore x="1823094" class="Procedure" value="Cryoglobulin Measurement" score="1.00" ID="C111164">Cryoglobulin </Semaphore>disappeared and <Semaphore x="2809034" class="MedDRA LLT" value="Blood immunoglobulin G decreased" score="1.00" ID="10005595">IgG decreased</Semaphore>. <Semaphore x="2682659" class="Disease or Finding" value="Varicose Vein" score="1.00" ID="C35114">Varicose veins </Semaphore>of right lower <Semaphore x="2104605" class="AnatomicStructure" value="Leg" score="1.00" ID="C32974">leg </Semaphore>also provided as history. Concomitant medications provided as <Semaphore x="964955" class="Medicine" value="oxyCODONE" score="0.49" ID="274021">Oxycodone</Semaphore>, <Semaphore x="103656" class="Medicine" value="Amlodipine" score="0.74" ID="239933">Amlodipine </Semaphore>Besilate, Daiphen, Vicclox, Takepron.ON 15Dec2012 the patient experienced <Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep vein thrombosis </Semaphore>(<Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">DVT</Semaphore>) presenting with <Semaphore x="2102828" class="Disease or Finding" value="Leg Pain" score="1.00" ID="C34764">pain in leg </Semaphore>in the morning, patient stayed home from work and in evening (approximately 1700 hours) the patient was discovered at home by wife, experiencing heavy breathing, emergency services called and arrived at 18: 30 hours to find patient with <Semaphore x="1846529" class="Procedure" value="Diagnostic Procedure" score="0.58" ID="C18020">O2 saturation </Semaphore>of 55%. At hospital <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>included <Semaphore x="2077944" class="Procedure" value="Intubation Procedure" score="1.00" ID="C37981">intubation </Semaphore>and vasopressor. Echo Doppler and <Semaphore x="1762050" class="AnatomicStructure" value="Chest" score="1.00" ID="C25389">Chest </Semaphore>CT was not done. On 16Dec2012 at 1: 35am the patient <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">expired</Semaphore>. <Semaphore x="1558453" class="Disease or Finding" value="Autopsy TNM Finding" score="1.00" ID="C48882">Autopsy </Semaphore>pending. <Semaphore x="2840727" class="MedDRA LLT" value="Cardiac failure acute" score="1.00" ID="10007556">Acute <Semaphore x="2010076" class="Disease or Finding" value="Heart Failure" score="1.00" ID="C50577">heart failure </Semaphore></Semaphore>was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed</Semaphore>. <Semaphore x="2614723" class="Disease or Finding" value="Thrombosis" score="1.00" ID="C26891">Thrombosis </Semaphore>of <Semaphore x="2104605" class="AnatomicStructure" value="Leg" score="1.00" ID="C32974">lower <Semaphore x="2112119" class="AnatomicStructure" value="Limb" score="1.00" ID="C12429">extremity </Semaphore></Semaphore>was suspected.Laboratory values provided as follows: On 31Oct2011 (baseline reported as start of <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid</Semaphore>): <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951"><Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">Platelet </Semaphore>count </Semaphore>(PLT) - 13.2, <Semaphore x="3223703" class="MedDRA LLT" value="Red blood cell count" score="1.00" ID="10038150"><Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286"><Semaphore x="1896266" class="Procedure" value="Erythrocyte Distribution Width Measurement" score="1.00" ID="C64800"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">Red <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">blood cell </Semaphore></Semaphore>
        <Semaphore x="3223703" class="MedDRA LLT" value="Red blood cell count" score="1.00" ID="10038150">count </Semaphore>
        </Semaphore>
       </Semaphore>
      </Semaphore>
     (<Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC</Semaphore></Semaphore>) - 241, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">Hemoglobin </Semaphore>(<Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB</Semaphore>) - 8.5, International <Semaphore x="2320043" class="Procedure" value="Normalized Quotient" score="1.00" ID="C54569">normalised </Semaphore>ratio (<Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR</Semaphore>) - 0.99, <Semaphore x="2433991" class="Procedure" value="Prothrombin Time" score="1.00" ID="C62656"><Semaphore x="1098124" class="Medicine" value="Prothrombin" score="0.74" ID="236753">Prothrombin </Semaphore>time </Semaphore>(<Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT</Semaphore>) - 11.8, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">Activated partial thromboplastin time </Semaphore>(<Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT</Semaphore>) - 30. In Sep2012: PLT - 18.5, <Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC </Semaphore>- 297, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB </Semaphore>- 10.5, <Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR </Semaphore>- 1.09, <Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT </Semaphore>- 12.6, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT </Semaphore>- 26.7. In Oct2012: PLT - 12.9, <Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC </Semaphore>- 269, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB </Semaphore>- 9.7, <Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR </Semaphore>- 1.11, <Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT </Semaphore>- 12.8, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT </Semaphore>- 28.7. in Nov2012: PLT - 14.2, <Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC </Semaphore>- 302, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB </Semaphore>- 10.8, <Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR </Semaphore>- 1.07, <Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT </Semaphore>- 12.2, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT </Semaphore>- 28.4.Comment by reporting <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>: <Semaphore x="2438847" class="Disease or Finding" value="Pulmonary Infarction" score="1.00" ID="C50714">Pulmonary infarction </Semaphore>was developed from <Semaphore x="2896219" class="MedDRA LLT" value="Deep vein thrombosis" score="1.00" ID="10051055"><Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep vein <Semaphore x="3277644" class="MedDRA LLT" value="Thrombosis" score="1.00" ID="10043607">thrombosis </Semaphore></Semaphore>
     </Semaphore>
    <Semaphore x="3277644" class="MedDRA LLT" value="Thrombosis" score="1.00" ID="10043607">due to <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple </Semaphore></Semaphore>
    <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">myeloma </Semaphore>and Revlimid/Dexamethasone <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>and worsened serious which <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">resulted </Semaphore>in <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">death</Semaphore>. <Semaphore x="1361170" class="Medicine" value="Warfarin" score="0.87" ID="196877">Warfarin </Semaphore>was prescribed, however the effect was not sufficient. <Semaphore x="2886478" class="MedDRA LLT" value="Cryoglobulinaemia" score="1.00" ID="10011474">Cryoglobulinaemia </Semaphore>was also suspected.The reporter's causal <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">assessment </Semaphore>was provided as follows:<Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">DVT</Semaphore>: <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid </Semaphore>(suspected), Lenadex (suspected), <Semaphore x="434155" class="Medicine" value="Decadron" score="0.87" ID="249384">Decadron </Semaphore>(not provided).Additional information will be requested.Additional information was received on 08Jan2013 from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>. Patient's date of birth provided. Start date of <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid </Semaphore><Semaphore x="4859317408759809" class="Medicine - Revlimid - Dose" value="5mg" score="0.49" ID="">5mg </Semaphore><Semaphore x="4859377538301953" class="Medicine - Revlimid - Frequency" value="every" score="0.49" ID="">every </Semaphore>other day was confirmed to be 14Nov2011. No further information was provided.SUSPICION OF <Semaphore x="2438847" class="Disease or Finding" value="Pulmonary Infarction" score="1.00" ID="C50714">PULMONARY INFARCTION</Semaphore>Additional information was received on 18Jan2013 from the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>. <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">Drug </Semaphore>information was updated as follows:LenaDex was started on 08/Dec2010, and concomitant medication <Semaphore x="1361170" class="Medicine" value="Warfarin" score="0.87" ID="196877">warfarin </Semaphore>was received from 28Feb2011 to 15Dec2012. <Semaphore x="434155" class="Medicine" value="Decadron" score="0.87" ID="249384">Decadron </Semaphore>was received for relapsed/refractory <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple myeloma</Semaphore>.The indications were reported for concomitant medications <Semaphore x="103656" class="Medicine" value="Amlodipine" score="0.74" ID="239933">Amlodipine </Semaphore>received for <Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117">hypertension</Semaphore>, <Semaphore x="1361170" class="Medicine" value="Warfarin" score="0.87" ID="196877">warfarin </Semaphore>for <Semaphore x="3277610" class="MedDRA LLT" value="Thrombosis prophylaxis" score="1.00" ID="10043634"><Semaphore x="2420563" class="Procedure" value="Preventive Intervention" score="1.00" ID="C15843">prophylaxis </Semaphore>of <Semaphore x="2614723" class="Disease or Finding" value="Thrombosis" score="1.00" ID="C26891">thrombosis</Semaphore>, Daiphen for <Semaphore x="2420563" class="Procedure" value="Preventive Intervention" score="1.00" ID="C15843">prophylaxis </Semaphore></Semaphore>
    <Semaphore x="3032994" class="MedDRA LLT" value="Infection prophylaxis" score="1.00" ID="10049924">of infection</Semaphore>, Vicclox received for <Semaphore x="2023494" class="Disease or Finding" value="Herpes" score="1.00" ID="C50583">herpes</Semaphore>, and Takepron for <Semaphore x="1964632" class="Disease or Finding" value="Gastric Ulcer" score="1.00" ID="C3388">gastric <Semaphore x="2660939" class="Disease or Finding" value="Ulcerated Oral Leukoplakia" score="1.00" ID="C4694">ulcer</Semaphore></Semaphore>.The serious <Semaphore x="2724216" class="MedDRA LLT" value="Adverse event" score="1.00" ID="10060933">adverse event </Semaphore>of suspicion of <Semaphore x="2438847" class="Disease or Finding" value="Pulmonary Infarction" score="1.00" ID="C50714">pulmonary infarction </Semaphore>was added as <Semaphore x="2724216" class="MedDRA LLT" value="Adverse event" score="1.00" ID="10060933">adverse event </Semaphore>occurring on 15Dec2012; and the <Semaphore x="2353087" class="Disease or Finding" value="Outcome Death" score="1.00" ID="C82549">outcome was <Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906">death </Semaphore></Semaphore>on 16Dec2012. The seriousness and <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>for the event of <Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep vein thrombosis </Semaphore>were amended to not provided and unknown, respectively. No test finding was performed.On 31Oct2011 (baseline reported as start of <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid</Semaphore>): <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951"><Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">Platelet </Semaphore>count </Semaphore>(PLT) (ref range 150-350 k/uL) 13.2, <Semaphore x="3223703" class="MedDRA LLT" value="Red blood cell count" score="1.00" ID="10038150"><Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286"><Semaphore x="1896266" class="Procedure" value="Erythrocyte Distribution Width Measurement" score="1.00" ID="C64800"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">Red <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">blood cell </Semaphore></Semaphore>
        <Semaphore x="3223703" class="MedDRA LLT" value="Red blood cell count" score="1.00" ID="10038150">count </Semaphore>
        </Semaphore>
       </Semaphore>
      </Semaphore>
     (<Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC</Semaphore></Semaphore>) (ref range 4300-5700 k/uL) 241, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">Hemoglobin </Semaphore>(<Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB</Semaphore>) (ref. range 13.5-17.0 g/dL) 8.5, International <Semaphore x="2320043" class="Procedure" value="Normalized Quotient" score="1.00" ID="C54569">normalised </Semaphore>ratio (<Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR</Semaphore>) (ref range 0.90-1.10) 0.99, <Semaphore x="2433991" class="Procedure" value="Prothrombin Time" score="1.00" ID="C62656"><Semaphore x="1098124" class="Medicine" value="Prothrombin" score="0.74" ID="236753">Prothrombin </Semaphore>time </Semaphore>(<Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT</Semaphore>) 11.8 <Semaphore x="2584410" class="Disease or Finding" value="Staphylococcal Food Poisoning" score="1.00" ID="C35037">sec</Semaphore>, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">Activated partial thromboplastin time </Semaphore>(<Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT</Semaphore>) (ref range 22.0-37.0 sec)30. On 03Sep2012: PLT - 18.5, <Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC </Semaphore>- 297, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB </Semaphore>- 10.5, <Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR </Semaphore>- 1.09, <Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT </Semaphore>- 12.6, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT </Semaphore>- 26.7. On 01Oct2012: PLT - 12.9, <Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC </Semaphore>- 269, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB </Semaphore>- 9.7, <Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR </Semaphore>- 1.11, <Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT </Semaphore>- 12.8, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT </Semaphore>- 28.7. On 26Nov2012: PLT -14.2, <Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946">RBC </Semaphore>- 302, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">HGB </Semaphore>- 10.8, <Semaphore x="2064167" class="Procedure" value="International Normalized Ratio of Prothrombin Time" score="1.00" ID="C64805">INR </Semaphore>- 1.07, <Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">PT </Semaphore>- 12.2, <Semaphore x="2379715" class="Procedure" value="Partial Thromboplastin Time" score="1.00" ID="C38462">APTT </Semaphore>- 28.4.The investigator assessed the causal relationship as follows:Suspicion of <Semaphore x="2438847" class="Disease or Finding" value="Pulmonary Infarction" score="1.00" ID="C50714">pulmonary infarction</Semaphore>: <Semaphore x="1131427" class="Medicine" value="Revlimid" score="1.00" ID="256603">Revlimid </Semaphore>(probable); LenDex (probable)</narrativeincludeclinical>
        <sendercomment lang="en">The temporal relationship between therapy and DEEP VEIN THROMBOSIS and DEATH DUE TO SUSPICION OF PULMONARY INFARCTION suggest that a causal relationship is possible, but underlying disease may provide an alternative explanation. A medical history of varicose veins of  lower extremity and Cryoglobulinemia may have been contributory for the event of DVT.  Additionally, co-suspect Lenadex and Decadron may have contributed to the event development. 

The event of death was now considered unlabeled in IB.</sendercomment>
      </summary>
    </patient>
  </safetyreport>
</ichicsr></original></faers>